OBJECTIVES: The role and clinical significance of fragile histidine triad (FHIT) gene in the pathogenesis of bladder urothelial carcinoma (UC) and the potential of Fhit protein as a prognostic biomarker for UC were investigated. METHODS: FHIT expression was determined according to semiquantitative immunohistochemical staining for Fhit protein levels in normal bladder and bladder UC tissues. Associations between FHIT expression, clinicopathological features and survival were evaluated. RESULTS: This study evaluated 42 cases of normal bladder and 125 cases of bladder UC; bladder UC cases had a median follow-up of 53.5 months. Immunohistochemistry showed that 95.2% of normal cases and 47.2% of bladder UC cases, respectively, were positive for Fhit protein; this difference was statistically significant. There was a significant association between negative FHIT expression in bladder UC and advanced tumour stage, high pathological grade, large tumour size, tumour recurrence and reduced survival time, but no association with age, gender, tumour number or tumour shape. CONCLUSIONS: The FHIT gene may have an important role in the pathogenesis of bladder UC and was expressed at lower levels in bladder UC compared with normal bladder tissue. Using Fhit protein as a biomarker could provide important information about patient prognosis.
ParkinDMBrayFFerlayJ: Global cancer statistics, 2002. CA Cancer J Clin2005; 55: 74–108.
2.
PhéVCussenotORouprêtM: Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract. BJU Int2009; 104: 896–901.
3.
SobinLHWittekindC, (eds): International Union Against Cancer (UICC): TNM Classification of Malignant Tumours, 6th edn.New York: Wiley—Liss, 2002.
4.
Mhawech-FaucegliaPCheneyRTSchwallerJ: Genetic alterations in urothelial bladder carcinoma: an updated review. Cancer2006; 106: 1205–1216.
5.
HaraIMiyakeHHaraS: Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder. J Urol2001; 165: 1769–1772.
6.
KrügerSThornsCBöhleA: Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder. Int Urol Nephrol2003; 35: 169–173.
7.
DruckTHadaczekPFuTB: Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res1997; 57: 504–512.
8.
KasturyKBaffaRDruckT: Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA 3B site identified by homozygous deletions in tumor cell lines. Cancer Res1996; 56: 978–983.
9.
SozziGPastorinoUMoiraghiL: Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res1998; 58: 5032–5037.
10.
CapuzziDSantoroEHauckWW: Fhit expression in gastric adenocarcinoma correlation with disease stage and survival. Cancer2000; 88: 24–34.
11.
IsmailHMMedhatAMKarimAM: FHIT gene and flanking region on chromosome 3p are subjected to extensive allelic loss in Egyptian breast cancer patients. Mol Carcinog2011; 50: 625–634.
12.
LeeYCWuCTShihJY: Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers. Br J Cancer2004; 90: 2378–2383.
13.
ZhengHCZhengYSXiaP: The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes. Histol Histopathol2010; 25: 445–452.
GiarnieriEZanesiNBottoniA: Oncosuppressor proteins of fragile sites are reduced in cervical cancer. Cancer Lett2010; 289: 40–45.
16.
KvashaSGordiyukVKondratovA: Hypermethylation of the 5′CpG island of the FHIT gene in clear cell renal carcinomas. Cancer Lett2008; 265: 250–257.
17.
MostofiFKSobinLHTorloniH, (eds): Histological Typing of Urinary Bladder Tumours. International Histological Classification of Tumours, No 10. Geneva: World Health Organization, 1973.
18.
ProctorIStoeberKWilliamsGH: Biomarkers in bladder cancer. Histopathology2010; 57: 1–13.
19.
ChenJHFaquinWCLloydRV: Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma. Mod Pathol2011; 24: 739–749.
20.
ShapiroJR: Genetic alterations associated with adult diffuse astrocytic tumors. Am J Med Genet2002; 115: 194–201.
21.
KhaledHMBahnassyAARaafatAA: Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer. BMC Cancer2009; 9: 32.
22.
GhalebKIAlkaladiA: Homozygous deletion of the FHIT gene, p21WAF1 protein expression and apoptosis in bilharzial bladder cancer. Pak J Biol Sci2011; 14: 212–218.
23.
AveyardJSKnowlesMA: Measurement of relative copy number of CDKN2A/ARF and CDKN2B in bladder cancer by real-time quantitative PCR and multiplex ligation-dependent probe amplification. J Mol Diagn2004; 6: 356–365.
24.
BaffaRGomellaLGVecchioneA: Loss of FHIT expression in transitional cell carcinoma of the urinary bladder. Am J Pathol2000; 156: 419–424.
25.
YanagawaNTamuraGOizumiH: Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking status. Anticancer Res2011; 31: 1211–1214.
26.
NeyazMKKumarRSHussainS: Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population. Biomarkers2008; 13: 597–606.
27.
WoenckhausMMerkJStoehrR: Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Hum Pathol2008; 39: 126–136.
28.
VecchioneASevignaniCGiarnieriE: Inactivation of the FHIT gene favors bladder cancer development. Clin Cancer Res2004; 10: 7607–7612.
29.
BianchiFTagliabueEMénardS: Fhit expression protects against HER2-driven breast tumor development: unraveling the molecular interconnections. Cell Cycle2007; 6: 643–646.
30.
RozLGramegnaMIshiiH: Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines. Proc Natl Acad Sci U S A2002; 99: 3615–3620.
31.
YutoriHSembaSKomoriT: Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cells. Cancer Sci2008; 99: 524–530.
32.
GoebellPJGroshenSGSchmitz-DrägerBJ: p53 immunohistochemistry in bladder cancer—a new approach to an old question. Urol Oncol2010; 28: 377–388.
33.
FrazierHARobertsonJEDodgeRK: The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer1993; 71: 3993–4001.
34.
HuangQXieFTangZ: FHIT promotes the apoptosis of QBC939 by reducing the expression of cyclin D1. Hepatogastroenterology2011; 58: 713–718.
35.
HigbeeDR: Value of preoperative radiation in reduction in size of single and multiple papillary bladder tumors. J Urol1955; 73: 498–501.
36.
LinYLSunGLiuXQ: Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma. J Int Med Res2011; 39: 179–186.
37.
CaiDWLiuXFBuRG: Genetic polymorphisms of MTHFR and aberrant promoter hypermethylation of the RASSF1A gene in bladder cancer risk in a Chinese population. J Int Med Res2009; 37: 1882–1889.
38.
MaruyamaRToyookaSToyookaKO: Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res2001; 61: 8659–8663.
39.
GulerGHimmetogluCJimenezRE: Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features. Breast Cancer Res Treat2011; 129: 421–432.
40.
SilveiraAPDa Silva Manoel-CaetanoFAokiS: Gene mutations and polymorphisms of TP53 and FHIT in chronic esophagitis and esophageal carcinoma. Anticancer Res2011; 31: 1685–1690.
41.
BloomstonMKneileJButterfieldM: Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features. Ann Surg Oncol2009; 16: 2331–2338.
42.
JinCJinYWennerbergJ: Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients. Mutat Res2008; 652: 30–37.
